InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Kunkel Lori Anne. Officer active across 3 companies, notably Oric Pharmaceuticals, Inc.. Aggregated, 11 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €739k. History available since 3 June 2024. The latest transaction was disclosed on 6 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Kunkel Lori Anne is a director of Enliven Therapeutics, Inc., Oric Pharmaceuticals, Inc. and Nurix Therapeutics, Inc. The record shows 6 filings in total. Across the most recent filings held, the period runs from 2024-06-04 to 2026-06-09, with EUR 297348 of sells and no buys; the modal transaction nature is Disposal.